• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于非编码RNA在乙肝病毒/共价闭合环状DNA驱动的肝癌进展中的观点。

Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression.

作者信息

Lin Yang-Hsiang, Lai Ming-Wei, Yeh Chau-Ting, Lin Wey-Ran

机构信息

Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.

Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Cancer Cell Int. 2025 Jun 21;25(1):224. doi: 10.1186/s12935-025-03849-0.

DOI:10.1186/s12935-025-03849-0
PMID:40544269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12182653/
Abstract

Hepatitis B virus (HBV) integration, the HBx protein (and its mutants), and covalently closed circular DNA (cccDNA) are critical for HBV replication, packaging, and transmission to new host cells. Although nucleos(t)ide analogs (NAs) are a class of antiviral drugs that effectively suppress HBV replication, they do not eliminate cccDNA. This persistent cccDNA, often referred to as an "invisible bullet", plays a pivotal role not only in the horizontal transmission of HBV but also within the context of hepatocellular carcinoma (HCC). Growing evidence reveals that noncoding RNAs (ncRNAs) are deeply involved in cancer progression, as well as the HBV life cycle and related pathogenesis, including liver inflammation, fibrosis, and HCC. This involvement occurs through various mechanisms, as ncRNAs regulate gene transcription, act as miRNA sponges, modulate signaling pathways, and influence downstream effects. These functions depend on the proper formation of RNA structures, which are critical for maintaining the biological activity of ncRNAs. The structure of RNAs appears to play a pivotal role in their functional capacity. Moreover, both ncRNAs and viral nucleotides contribute to G-quadruplex structure formation, which is essential for the HBV life cycle and cancer progression. In this review, we provide an updated overview of the mechanisms by which key ncRNAs mediate HBV/cccDNA actions in HCC progression and focus on their roles in gene expression and structural formation/modification.

摘要

乙型肝炎病毒(HBV)整合、HBx蛋白(及其突变体)和共价闭合环状DNA(cccDNA)对于HBV复制、包装以及向新宿主细胞的传播至关重要。尽管核苷(酸)类似物(NAs)是一类能有效抑制HBV复制的抗病毒药物,但它们并不能消除cccDNA。这种持续存在的cccDNA,常被称为“隐形子弹”,不仅在HBV的水平传播中起关键作用,而且在肝细胞癌(HCC)的背景下也发挥着重要作用。越来越多的证据表明,非编码RNA(ncRNAs)深度参与癌症进展以及HBV生命周期和相关发病机制,包括肝脏炎症、纤维化和HCC。这种参与通过多种机制发生,因为ncRNAs调节基因转录、充当miRNA海绵、调节信号通路并影响下游效应。这些功能取决于RNA结构的正确形成,而RNA结构对于维持ncRNAs的生物学活性至关重要。RNA的结构似乎在其功能能力中起关键作用。此外,ncRNAs和病毒核苷酸都有助于G-四链体结构的形成,这对于HBV生命周期和癌症进展至关重要。在本综述中,我们提供了关键ncRNAs在HCC进展中介导HBV/cccDNA作用机制的最新概述,并重点关注它们在基因表达和结构形成/修饰中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/9e5dbc3ed50e/12935_2025_3849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/84182e4c9b15/12935_2025_3849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/ad0ef32aeb00/12935_2025_3849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/9e5dbc3ed50e/12935_2025_3849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/84182e4c9b15/12935_2025_3849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/ad0ef32aeb00/12935_2025_3849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc8e/12182653/9e5dbc3ed50e/12935_2025_3849_Fig3_HTML.jpg

相似文献

1
Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression.关于非编码RNA在乙肝病毒/共价闭合环状DNA驱动的肝癌进展中的观点。
Cancer Cell Int. 2025 Jun 21;25(1):224. doi: 10.1186/s12935-025-03849-0.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
4
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
5
A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.一项微小RNA筛选确定Wnt信号通路是黄病毒感染期间干扰素反应的调节因子。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.02388-16. Print 2017 Apr 15.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.肝细胞癌肝硬化监测:系统评价与经济分析
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.

本文引用的文献

1
MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial-mesenchymal transition in hepatocellular carcinoma.微小RNA-101-3p通过Birc5靶向PI3K-AKT信号通路,以抑制肝细胞癌的侵袭、增殖和上皮-间质转化。
Clin Exp Med. 2025 Mar 19;25(1):88. doi: 10.1007/s10238-025-01622-1.
2
Small molecule as potent hepatocellular carcinoma progression inhibitor through stabilizing G-quadruplex DNA to activate replication stress responded DNA damage.小分子作为强效的肝细胞癌进展抑制剂,通过稳定G-四链体DNA来激活复制应激反应性DNA损伤。
Chem Biol Interact. 2025 May 1;412:111469. doi: 10.1016/j.cbi.2025.111469. Epub 2025 Mar 7.
3
Pathological roles of lncRNA HOTAIR in liver cancer: An updated review.
长链非编码RNA HOTAIR在肝癌中的病理作用:最新综述
Gene. 2025 Mar 10;940:149180. doi: 10.1016/j.gene.2024.149180. Epub 2024 Dec 19.
4
The novel role of LOC344887 in the enhancement of hepatocellular carcinoma progression via modulation of SHP1-regulated STAT3/HMGA2 signaling axis.LOC344887通过调节SHP1调控的STAT3/HMGA2信号轴在促进肝细胞癌进展中的新作用。
Int J Biol Sci. 2024 Dec 2;20(15):6281-6296. doi: 10.7150/ijbs.99683. eCollection 2024.
5
5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis.MALAT1的5-甲基胞嘧啶甲基化通过ELAVL1/SLC7A11介导的铁死亡促进肝癌对索拉非尼的耐药性。
Drug Resist Updat. 2025 Jan;78:101181. doi: 10.1016/j.drup.2024.101181. Epub 2024 Dec 4.
6
Small and long non-coding RNAs: Past, present, and future.小长非编码 RNA:过去、现在和未来。
Cell. 2024 Nov 14;187(23):6451-6485. doi: 10.1016/j.cell.2024.10.024.
7
Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA.表观遗传调控及其在乙型肝炎病毒共价闭合环状DNA中的治疗潜力。
Genes Dis. 2024 Feb 3;12(1):101215. doi: 10.1016/j.gendis.2024.101215. eCollection 2025 Jan.
8
LncRNA MALAT1 promotes Erastin-induced ferroptosis in the HBV-infected diffuse large B-cell lymphoma.长链非编码 RNA MALAT1 促进乙型肝炎病毒感染的弥漫大 B 细胞淋巴瘤中依维莫司诱导的铁死亡。
Cell Death Dis. 2024 Nov 12;15(11):819. doi: 10.1038/s41419-024-07209-0.
9
Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma.miR-101-UBE2D1轴的异常激活促进了人类肝细胞癌的进展及化疗敏感性。
Cell Death Discov. 2024 Oct 1;10(1):422. doi: 10.1038/s41420-024-02193-y.
10
Upregulated PrP by HBx enhances NF-κB signal via liquid-liquid phase separation to advance liver cancer.HBx上调的PrP通过液-液相分离增强NF-κB信号以促进肝癌发展。
NPJ Precis Oncol. 2024 Sep 27;8(1):211. doi: 10.1038/s41698-024-00697-5.